{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:50:51Z","timestamp":1786989051674,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004637","name":"Nanchang University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060451"],"award-info":[{"award-number":["82060451"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160203"],"award-info":[{"award-number":["82160203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.exer.2025.110486","type":"journal-article","created":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T10:03:38Z","timestamp":1749981818000},"page":"110486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["TLR4 signal inhibition alleviates alkali-burn induced corneal neovascularization"],"prefix":"10.1016","volume":"258","author":[{"given":"Cong","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lumei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojuan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1670-5449","authenticated-orcid":false,"given":"Hongping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2025.110486_bib1","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","article-title":"VEGF in signaling and disease: beyond discovery and development","volume":"176","author":"Apte","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.exer.2025.110486_bib2","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American ophthalmological society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.exer.2025.110486_bib3","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0962-8924(01)02064-5","article-title":"Signal transduction by tumor necrosis factor and its relatives","volume":"11","author":"Baud","year":"2001","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.exer.2025.110486_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yjmcc.2021.08.001","article-title":"MyD88: at the heart of inflammatory signaling and cardiovascular disease","volume":"161","author":"Bayer","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.exer.2025.110486_bib5","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exer.2025.110486_bib6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejpb.2020.08.022","article-title":"In vivo biocompatibility and efficacy of dexamethasone-loaded PLGA-PEG-PLGA thermogel in an alkali-burn induced corneal neovascularization disease model","volume":"155","author":"Chan","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.exer.2025.110486_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":"Corneal neovascularization: an Anti-VEGF therapy review","volume":"57","author":"Chang","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110486_bib8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.exer.2018.07.001","article-title":"TLR4-MyD88 pathway promotes the imbalanced activation of NLRP3\/NLRP6 via caspase-8 stimulation after alkali burn injury","volume":"176","author":"Chen","year":"2018","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110486_bib9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/ni1388","article-title":"Host-pathogen interactions in drosophila: new tricks from an old friend","volume":"7","author":"Cherry","year":"2006","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.exer.2025.110486_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2025.110486_bib11","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1167\/iovs.16-21283","article-title":"Inhibition of placenta growth factor reduces subretinal mononuclear phagocyte accumulation in choroidal neovascularization","volume":"58","author":"Crespo-Garcia","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110486_bib12","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1073\/pnas.91.9.4082","article-title":"Thalidomide is an inhibitor of angiogenesis","volume":"91","author":"D'Amato","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.exer.2025.110486_bib13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.22336\/rjo.2021.58","article-title":"Treating corneal neovascularization using a combination of anti-VEGF injection and argon laser photocoagulation application - case report","volume":"65","author":"Donato","year":"2021","journal-title":"Rom J Ophthalmol"},{"key":"10.1016\/j.exer.2025.110486_bib14","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jacc.2007.01.089","article-title":"Plaque neovascularization and antiangiogenic therapy for atherosclerosis","volume":"49","author":"Doyle","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.exer.2025.110486_bib15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/02713683.2018.1564833","article-title":"Protective effect of TLR4 ablation against corneal neovascularization following chemical burn in a mouse model","volume":"44","author":"Friedman","year":"2019","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2025.110486_bib16","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1172\/JCI200317573","article-title":"Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection","volume":"111","author":"Goldstein","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.exer.2025.110486_bib17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/glia.21094","article-title":"Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NF\u03baB signaling, MAPK, and Jak1\/Stat1 pathways","volume":"59","author":"Gorina","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.exer.2025.110486_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-065X.2008.00697.x","article-title":"Interleukin-2 in the development and control of inflammatory disease","volume":"226","author":"Hoyer","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.exer.2025.110486_bib19","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.neuroscience.2010.08.054","article-title":"Toll-like receptor 4 (TLR4), but not TLR3 or TLR9, knock-out mice have neuroprotective effects against focal cerebral ischemia","volume":"171","author":"Hyakkoku","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.exer.2025.110486_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041232","article-title":"Resistance to anti-angiogenic therapy in cancer-alterations to Anti-VEGF pathway","volume":"19","author":"Itatani","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110486_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313150","article-title":"AS1411 nucleolin-specific binding aptamers reduce pathological angiogenesis through inhibition of nucleolin phosphorylation","volume":"22","author":"Iturriaga-Goyon","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110486_bib22","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1159\/000453165","article-title":"IL-35 inhibits angiogenesis through VEGF\/Ang2\/Tie2 pathway in rheumatoid arthritis","volume":"40","author":"Jiang","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.exer.2025.110486_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.exer.2025.110486_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184411","article-title":"Vascular endothelial cell biology: an update","volume":"20","author":"Kr\u00fcger-Genge","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2025.110486_bib25","first-page":"14","article-title":"Forkhead domain Inhibitor-6 suppresses corneal neovascularization and subsequent fibrosis after alkali burn in rats","volume":"63","author":"Lan","year":"2022","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110486_bib26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00018-010-0476-6","article-title":"Bone marrow-derived mesenchymal cells and MMP13 contribute to experimental choroidal neovascularization","volume":"68","author":"Lecomte","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.exer.2025.110486_bib27","article-title":"Critical role of TNF-\u03b1-Induced macrophage VEGF and iNOS production in the experimental corneal neovascularization","volume":"53","author":"Lu","year":"2012","journal-title":"Investigative Opthalmology & Visual Science"},{"key":"10.1016\/j.exer.2025.110486_bib28","article-title":"Enhanced experimental corneal neovascularization along with aberrant angiogenic factor expression in the absence of IL-1 receptor antagonist","volume":"50","author":"Lu","year":"2009","journal-title":"Investigative Opthalmology & Visual Science"},{"key":"10.1016\/j.exer.2025.110486_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112274","article-title":"Inhibiting corneal neovascularization by sustainably releasing anti-VEGF and anti-inflammation drugs from silica-thermogel nanohybrids","volume":"128","author":"Lyu","year":"2021","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.exer.2025.110486_bib30","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S1542-0124(12)70308-7","article-title":"Matrix revolution: molecular mechanism for inflammatory corneal neovascularization and restoration of corneal avascularity by epithelial stem cell transplantation","volume":"7","author":"Ma","year":"2009","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.exer.2025.110486_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5402\/2012\/701950","article-title":"Innate immune regulation by toll-like receptors in the brain","volume":"2012","author":"Mallard","year":"2012","journal-title":"ISRN Neurology"},{"key":"10.1016\/j.exer.2025.110486_bib32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.exer.2025.110486_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.108363","article-title":"Corneal neovascularization","volume":"202","author":"Nicholas","year":"2021","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110486_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular endothelial growth factor in eye disease","volume":"27","author":"Penn","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2025.110486_bib35","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1182\/blood-2006-06-028704","article-title":"Toll-like receptors and their ligands control mesenchymal stem cell functions","volume":"109","author":"Pevsner-Fischer","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exer.2025.110486_bib36","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00417-016-3409-8","article-title":"Tissue and cellular characterisation of nucleolin in a murine model of corneal angiogenesis","volume":"254","author":"Quiroz-Mercado","year":"2016","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110486_bib37","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","article-title":"A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis","volume":"38","author":"Rice","year":"2010","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.exer.2025.110486_bib38","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.exer.2006.07.015","article-title":"Lipopolysaccharide from Escherichia coli induces the expression of vascular endothelial growth factor via toll-like receptor 4 in human limbal fibroblasts","volume":"83","author":"Rodr\u00edguez-Mart\u00ednez","year":"2006","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110486_bib39","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/ncb1629","article-title":"Toll-like receptors modulate adult hippocampal neurogenesis","volume":"9","author":"Rolls","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.exer.2025.110486_bib40","doi-asserted-by":"crossref","first-page":"C75","DOI":"10.1152\/ajpcell.00332.2006","article-title":"Effect of overexpression of PPARgamma on the healing process of corneal alkali burn in mice","volume":"293","author":"Saika","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.exer.2025.110486_bib41","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.phrs.2016.03.038","article-title":"Modulation of endothelial function by toll like receptors","volume":"108","author":"Salvador","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.exer.2025.110486_bib42","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/cvr\/cvr075","article-title":"The vascular repair process after injury of the carotid artery is regulated by IL-1RI and MyD88 signalling","volume":"91","author":"Saxena","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.exer.2025.110486_bib43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/187221309789257450","article-title":"Corneal neovascularization: molecular events and therapeutic options","volume":"3","author":"Shakiba","year":"2009","journal-title":"Recent Pat. Inflamm. Allergy Drug Discov."},{"key":"10.1016\/j.exer.2025.110486_bib44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.22336\/rjo.2019.4","article-title":"Corneal neovascularization: updates on pathophysiology, investigations & management","volume":"63","author":"Sharif","year":"2019","journal-title":"Rom J Ophthalmol"},{"key":"10.1016\/j.exer.2025.110486_bib45","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.survophthal.2017.09.005","article-title":"Treatment of acute ocular chemical burns","volume":"63","author":"Sharma","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2025.110486_bib46","doi-asserted-by":"crossref","first-page":"I270","DOI":"10.1161\/CIRCULATIONAHA.105.000901","article-title":"Inhibition of toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury","volume":"114","author":"Shimamoto","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.exer.2025.110486_bib47","doi-asserted-by":"crossref","first-page":"9108","DOI":"10.1167\/iovs.11-7255","article-title":"Doxycycline enhances the inhibitory effects of bevacizumab on corneal neovascularization and prevents its side effects","volume":"52","author":"Su","year":"2011","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110486_bib48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.omtm.2021.06.007","article-title":"Efficacious, safe, and stable inhibition of corneal neovascularization by AAV-Vectored anti-VEGF therapeutics","volume":"22","author":"Su","year":"2021","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.exer.2025.110486_bib49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/iovs.65.1.37","article-title":"The secreted Ly6\/uPAR-Related protein 1 (Slurp1) modulates corneal angiogenic inflammation via NF-\u03baB signaling","volume":"65","author":"Swamynathan","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110486_bib50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1189\/jlb.0902436","article-title":"The critical role of ocular-infiltrating macrophages in the development of choroidal neovascularization","volume":"74","author":"Tsutsumi","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.exer.2025.110486_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2021.100954","article-title":"VEGFR1 signaling in retinal angiogenesis and microinflammation","volume":"84","author":"Uemura","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.exer.2025.110486_bib52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1189\/jlb.2RI1115-531R","article-title":"TRIF-Dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target","volume":"100","author":"Ullah","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.exer.2025.110486_bib53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5935\/0004-2749.20220004","article-title":"Comparison of the inhibitory effect of topical cyclosporine A 0.1% and topical anti-VEGF application in an experimental model of corneal neovascularization","volume":"85","author":"Ulusoy","year":"2022","journal-title":"Arq. Bras. Oftalmol."},{"key":"10.1016\/j.exer.2025.110486_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2020.107977","article-title":"Corneal neovascularization is inhibited with nucleolin-binding aptamer, AS1411","volume":"193","author":"Vivanco-Rojas","year":"2020","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2025.110486_bib55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1167\/iovs.65.1.21","article-title":"Exploring corneal neovascularization: an integrated approach using transcriptomics and proteomics in an Alkali Burn mouse model","volume":"65","author":"Wang","year":"2024","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2025.110486_bib56","doi-asserted-by":"crossref","first-page":"S224","DOI":"10.1016\/j.semcancer.2015.01.001","article-title":"Broad targeting of angiogenesis for cancer prevention and therapy","volume":"35","author":"Wang","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.exer.2025.110486_bib57","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1126\/science.1087262","article-title":"Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway","volume":"301","author":"Yamamoto","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.exer.2025.110486_bib58","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1111\/bph.15046","article-title":"Direct inhibition of the TLR4\/MyD88 pathway by geniposide suppresses HIF-1\u03b1-independent VEGF expression and angiogenesis in hepatocellular carcinoma","volume":"177","author":"Zhang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2025.110486_bib59","first-page":"1427","article-title":"Expression of cell adhesion molecules on limbal and neovascular endothelium in corneal inflammatory neovascularization","volume":"40","author":"Zhu","year":"1999","journal-title":"Investig. Ophthalmol. Vis. Sci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448352500257X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448352500257X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:20:41Z","timestamp":1778898041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448352500257X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":59,"alternative-id":["S001448352500257X"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2025.110486","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TLR4 signal inhibition alleviates alkali-burn induced corneal neovascularization","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2025.110486","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110486"}}